Literature DB >> 12123688

Inhibition of spinal protein kinase Calpha expression by an antisense oligonucleotide attenuates morphine infusion-induced tolerance.

X-Y Hua1, A Moore, S Malkmus, S F Murray, N Dean, T L Yaksh, M Butler.   

Abstract

Protein kinase C isoforms including the alpha isozyme have been implicated in morphine tolerance. In the present study, we examined the effect of intrathecal delivery of an antisense oligonucleotide targeting rat protein kinase Calpha mRNA on the expression of spinal protein kinase Calpha isozyme and spinal morphine tolerance. Continuous intrathecal infusion of rats with morphine produced an increase in paw withdrawal threshold to thermal stimulation on day 1, which disappeared by day 5. On day 6, a bolus intrathecal injection of morphine (a probe dose) produced significantly less analgesia in morphine-infused rats than in saline-infused rats, suggesting tolerance. Intrathecal treatment with the protein kinase Calpha antisense concurrent with spinal morphine infusion not only maintained the analgesic effect of morphine during the 5-day infusion, it also significantly increased responsiveness to the probe morphine dose on day 6. In comparison, the missense used in the same treatment paradigm had no effect. The inhibitory effect of protein kinase Calpha antisense on spinal morphine tolerance was dose-dependent, and reversible. Intrathecal treatment with the antisense, but not the missense, in rats decreased expression of spinal protein kinase Calpha mRNA and protein, as revealed by real-time quantitative reverse transcription-polymerase chain reaction and western blots. Expression of the gamma isozyme was not affected by the oligonucleotides. The antisense also attenuated protein kinase C-mediated phosphorylation in spinal cord. These results demonstrate that selective reduction in the expression of the spinal protein kinase Calpha isozyme followed by a decrease of local protein kinase C-mediated phosphorylation will reverse spinal morphine infusion-induced tolerance. This finding is consistent with the view that tolerance produced by morphine infusion is dependent upon an increase in phosphorylation by protein kinase C, and also it emphasizes that the protein kinase Calpha isozyme and its activation in spinal cord may specifically participate in the phenomenon of opiate tolerance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12123688     DOI: 10.1016/s0306-4522(02)00157-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  12 in total

1.  Spinal mediators that may contribute selectively to antinociceptive tolerance but not other effects of morphine as revealed by deletion of GluR5.

Authors:  A M Gregus; C N Inra; T P Giordano; A C S Costa; A M Rajadhyaksha; C E Inturrisi
Journal:  Neuroscience       Date:  2010-03-29       Impact factor: 3.590

2.  Pre-treatment with a PKC or PKA inhibitor prevents the development of morphine tolerance but not physical dependence in mice.

Authors:  Bichoy H Gabra; Chris P Bailey; Eamonn Kelly; Forrest L Smith; Graeme Henderson; William L Dewey
Journal:  Brain Res       Date:  2008-04-24       Impact factor: 3.252

Review 3.  Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance.

Authors:  Kirsten M Raehal; Cullen L Schmid; Chad E Groer; Laura M Bohn
Journal:  Pharmacol Rev       Date:  2011-08-26       Impact factor: 25.468

Review 4.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

5.  Inhibition of spinal cytosolic phospholipase A(2) expression by an antisense oligonucleotide attenuates tissue injury-induced hyperalgesia.

Authors:  D H Kim; B Fitzsimmons; M P Hefferan; C I Svensson; E Wancewicz; B P Monia; G Hung; M Butler; M Marsala; X-Y Hua; T L Yaksh
Journal:  Neuroscience       Date:  2008-04-30       Impact factor: 3.590

6.  Evidence for an important role of protein phosphatases in the mechanism of morphine tolerance.

Authors:  Bichoy H Gabra; Chris P Bailey; Eamonn Kelly; Amanda V Sanders; Graeme Henderson; Forrest L Smith; William L Dewey
Journal:  Brain Res       Date:  2007-05-21       Impact factor: 3.252

7.  Agonist-dependent mu-opioid receptor signaling can lead to heterologous desensitization.

Authors:  Ji Chu; Hui Zheng; Yuhan Zhang; Horace H Loh; Ping-Yee Law
Journal:  Cell Signal       Date:  2010-01-05       Impact factor: 4.315

8.  Heterologous regulation of agonist-independent μ-opioid receptor phosphorylation by protein kinase C.

Authors:  Susann Illing; Anika Mann; Stefan Schulz
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 9.  Agonist-selective mechanisms of GPCR desensitization.

Authors:  E Kelly; C P Bailey; G Henderson
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

10.  Role of protein kinase C and mu-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons.

Authors:  C P Bailey; J Llorente; B H Gabra; F L Smith; W L Dewey; E Kelly; G Henderson
Journal:  Eur J Neurosci       Date:  2009-01       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.